Posts In: Gubba Pharma In E News

Great Place to Work® India has recognized Dr. Satyanarayana Chava, Founder & CEO, Laurus Labs.

August 18, 2021 Gubba Pharma In E News

With great excitement, we would like to announce that Great Place to Work® India has recognized Dr. Satyanarayana Chava, Founder & CEO, Laurus Labs, as...

Continue Reading

Rs. 500 Cr MoU Signed for API Unit in Himachal Pradesh

August 18, 2021 Gubba Pharma In E News

A Memorandum of Understanding (MoU) was signed between the State Government and Concord Biotech Limited in presence of Chief Minister Jai Ram Thakur, for setting...

Continue Reading

Indian Immunologicals Ltd produces Covaxin drug substance in record time

August 18, 2021 Gubba Pharma In E News

In order to augment the Covid 19 vaccine production capacity in our country so that a significant percentage of the population can get vaccinated at...

Continue Reading

Zydus Cadila ZyCoV-D Likely To Get Emergency Use Nod This Week: Sources

August 11, 2021 Gubba Pharma In E News

COVID-19 vaccine ZyCoV-D is expected to get an emergency-use nod from the expert committee this week, sources said. Union Health Minister Mansukh Mandaviya last week...

Continue Reading

Pharma cos foray into digital healthcare to bolster personalised care in India: GlobalData

August 11, 2021 Gubba Pharma In E News

Since 2019, there has been an increase in the adoption of digital health technology in India, with collaborations among pharmaceutical companies, insurance companies and digital...

Continue Reading

A call to action for made-in-India APIs

August 11, 2021 Gubba Pharma In E News

As global pharma looks for alternatives to Chinese sources, India builds local capacity for specialised, novel active ingredients In April 2020, the Indian pharmaceuticals industry...

Continue Reading

Uniza Group ties up with USA Companies for launching innovative products for Indian markets

August 4, 2021 Gubba Pharma In E News

Uniza Group , an Ahmedabad based young Pharma company celebrating its first year of operations has entered into an exclusive tie-up with Lysulin Inc –...

Continue Reading

Three pharma companies want to operate Tamil Nadu vax park

August 4, 2021 Gubba Pharma In E News

After initial invitation of bids failed to yield results, three pharmaceutical companies — Arvind, Morepen and Covaxin-maker Bharat Biotech — have now expressed interest to...

Continue Reading

India, U.K. to conduct clinical trials of ‘Ashwagandha’ for promoting recovery from COVID-19

August 4, 2021 Gubba Pharma In E News

Clinical trials will be conducted on 2,000 people in three U.K. cities, says Ministry of Ayush The Ministry of Ayush has collaborated with the U.K.’s...

Continue Reading